journal article·2015-02

Porous Silicon Nanodiscs for Targeted Drug Delivery

Hashim Alhmoud, Bahman Delalat, Roey Elnathan, Anna Cifuentes‐Rius, Arnaud Chaix, Mary‐Louise Rogers, Jean‐Olivier Durand, Nicolas H. Voelcker

Advanced Functional Materials· Volume 25· Issue 7
Publisher page

Abstract

There is a strong demand for techniques that allow the fabrication of biocompatible porous nanoparticles for drug delivery applications. In this work, a new method to fabricate size‐ and shape‐controlled porous silicon (pSi) nanodiscs is described. The process relies on a combination of colloidal lithography and metal‐assisted chemical etching. Height and diameter of the pSi nanodiscs can be easily adjusted. The nanodiscs are degradable in physiological milieu and are nontoxic to mammalian cells. In order to highlight the potential of the pSi nanodiscs in drug delivery, an in vitro investigation that involved loading of nanodiscs with the anticancer agent camptothecin and functionalization of the nanodisc periphery with an antibody that targets receptors on the surface of neuroblastoma cells is carried out. The thus‐prepared nanocarriers are found to selectively attach to and kill cancer cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Silicon Nanostructures and Photoluminescence · Nanowire Synthesis and Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Mawson Institute University of South Australia Mawson Lakes SA 5095 Australia

Institut Charles Gerhardt Montpellier (ICGM) Université Montpellier 2 34095 Montpellier France

Department of Human Physiology Centre for Neuroscience Flinders University Bedford Park SA 5042 Australia

References (59)

Show source-provided references
1. 10.1016/j.ejpb.2007.08.00110.1016/j.ejpb.2007.08.001 ↗
2. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
3. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
4. 10.1038/nrc90310.1038/nrc903 ↗
5. 10.1002/adhm.20120033510.1002/adhm.201200335 ↗
6. 10.1016/j.addr.2008.03.01210.1016/j.addr.2008.03.012 ↗
7. 10.1002/adfm.20120086910.1002/adfm.201200869 ↗
8. Ahmad I. · Cancer Res. · 1993 · 53 · 1484
9. 10.1016/j.ijpharm.2009.12.06110.1016/j.ijpharm.2009.12.061 ↗
10. 10.1016/S0924-8579(99)00121-110.1016/S0924-8579(99)00121-1 ↗
11. 10.1016/S1359-0286(02)00117-110.1016/S1359-0286(02)00117-1 ↗
12. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
13. 10.1016/j.biomaterials.2004.07.05010.1016/j.biomaterials.2004.07.050 ↗
14. 10.1021/mp050020d10.1021/mp050020d ↗
15. 10.1021/nl061412u10.1021/nl061412u ↗
16. 10.1016/j.ijpharm.2012.04.05610.1016/j.ijpharm.2012.04.056 ↗
17. 10.1039/c1cc11760b10.1039/c1cc11760b ↗
18. 10.1002/anie.20120673710.1002/anie.201206737 ↗
19. 10.1038/nmat239810.1038/nmat2398 ↗
20. 10.1016/S0162-0134(97)10016-210.1016/S0162-0134(97)10016-2 ↗
21. 10.1002/anie.20060448810.1002/anie.200604488 ↗
22. 10.1021/cm950608k10.1021/cm950608k ↗
23. 10.1016/j.jconrel.2005.08.01710.1016/j.jconrel.2005.08.017 ↗
24. 10.1002/smll.20090000510.1002/smll.200900005 ↗
25. 10.1021/ja910846q10.1021/ja910846q ↗
26. 10.1073/pnas.060099710310.1073/pnas.0600997103 ↗
27. 10.1073/pnas.070532610410.1073/pnas.0705326104 ↗
28. 10.1016/j.jconrel.2007.03.02210.1016/j.jconrel.2007.03.022 ↗
29. Lee T.‐R. · Sci. Rep. · 2013 · 3
30. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
31. 10.1016/j.jconrel.2009.10.01410.1016/j.jconrel.2009.10.014 ↗
32. 10.1073/pnas.130834511010.1073/pnas.1308345110 ↗
33. 10.2217/nnm.13.19110.2217/nnm.13.191 ↗
34. 10.1038/nnano.2008.3410.1038/nnano.2008.34 ↗
35. 10.1021/nl901759410.1021/nl9017594 ↗
36. 10.1007/s11671-010-9719-610.1007/s11671-010-9719-6 ↗
37. 10.1021/jp212427g10.1021/jp212427g ↗
38. S.Weidemann M.Kockert D.Wallacher M.Ramsteiner A.Mogilatenko K.Rademann S. F.Fischer arXiv preprint arXiv:1410.3763 2014.
39. 10.1002/adfm.20100036010.1002/adfm.201000360 ↗
40. 10.1002/adfm.20040060210.1002/adfm.200400602 ↗
41. 10.1063/1.157317310.1063/1.1573173 ↗
42. 10.1021/nl802747610.1021/nl8027476 ↗
43. 10.1021/nn901657w10.1021/nn901657w ↗
44. 10.1021/jp102174y10.1021/jp102174y ↗
45. 10.1021/la047781s10.1021/la047781s ↗
46. 10.1016/S0040-6090(96)09484-910.1016/S0040-6090(96)09484-9 ↗
47. Li L. H. · Cancer Res. · 1972 · 32 · 2643
48. 10.1039/c3py01245j10.1039/c3py01245j ↗
49. Gottleib J. · Cancer Chemother. Rep. · 1970 · 54 · 461
50. 10.1016/S0168-3659(03)00241-410.1016/S0168-3659(03)00241-4 ↗
51. 10.1002/smll.20070000510.1002/smll.200700005 ↗
52. 10.1016/j.ijpharm.2011.05.02110.1016/j.ijpharm.2011.05.021 ↗
53. 10.1021/nn404166q10.1021/nn404166q ↗
54. 10.1016/j.micromeso.2008.07.00210.1016/j.micromeso.2008.07.002 ↗
55. 10.1002/jnr.2150710.1002/jnr.21507 ↗
56. 10.1371/journal.pone.003068410.1371/journal.pone.0030684 ↗
57. 10.3389/fnmol.2014.0008010.3389/fnmol.2014.00080 ↗
58. 10.1016/j.jneumeth.2006.05.02210.1016/j.jneumeth.2006.05.022 ↗
59. 10.1021/ac00277a01810.1021/ac00277a018 ↗